Entourage Effect Capital (formerly Cresco Capital Partners) is a Dallas-based private equity investment firm founded in 2014, dedicated to investing in the cannabis industry. The firm has invested over $140 million in more than 60 cannabis companies and is currently deploying its third flagship fund.
50% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-a (50% of deals). Average disclosed round size is $8.0M (across 4 rounds with reported amounts).
Portfolio
6
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 BioLumic, Inc. | Series B | — | Jun 2022 |
 Phylos | Unknown | $7.6M | Feb 2022 |
 Cellibre | Series A | $11.5M | Oct 2021 |
 Hound Labs | Growth | — | Jan 2021 |
 Hoodie Analytics | Series A | $5M | — |
 Arcview Group | Series A | $7.7M | — |
Top Co-Investors
Merida Capital Holdings2 shared
Information Venture Partners1 shared
Delta Emerald Ventures1 shared
Accomplice1 shared
Slow Ventures1 shared
Benchmark1 shared
Icon Ventures1 shared
Main Street Advisors1 shared
Finistere Ventures1 shared
OurCrowd1 shared
Rabo Investments1 shared
iSelect Fund1 shared
Rabobank1 shared
Nexus Venture Partners1 shared
TechNexus Venture Collaborative1 shared
Last updated: 20 October 2026